Home › Companies › Guardant Health, Inc. › 2025-2026

Guardant Health, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Guardant Health, Inc.’s Form 8-K, filed 2026-06-18 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 8Reported items
  • 495Asset managers
  • 3,780Fund votes
  • 2026-06-17Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Guardant Health, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Guardant Health, Inc.

These tallies are Guardant Health, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-18 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Guardant Health, Inc. — official shareholder meeting results, meeting held 2026-06-17
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Ian Clark 70,526,891---- 37,916,5487,714,711 Majority: yes
Elect Director: Manuel Hidalgo Medina 81,925,123---- 26,518,3167,714,711 Majority: yes
Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was not approved by the following vote: 98,236,6399,905,190301,610 --7,714,711 Majority: yes

Source: Guardant Health, Inc., Form 8-K, filed with the SEC on 2026-06-18 — read the filing on EDGAR.

How asset managers voted at the Guardant Health, Inc. 2025-2026 meeting

Each item below shows how the 495 asset managers that disclosed a Guardant Health, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Guardant Health, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-06-17.

Combines 12 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 98,236,639AGAINST: 9,905,190

Guardant Health, Inc.’s own tally for this item (“Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was not approved by the following vote:”): 98,236,639 for, 9,905,190 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,599,929 outstanding shares: 74% for, 7% against (82% of the company cast a for/against vote).

The 491 asset managers below cast 88% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 88%12%
FOR: 87.7%AGAINST: 12.2%ABSTAIN: 0.1%NOT VOTED: 0.0%
Largest asset managers voting on “Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard14,227,2746 10For
T. Rowe Price12,020,9360 00For
Fidelity11,942,5780 00For
BlackRock9,109,5750 00For
Invesco22,9987,011,360 00Against
Capital Group06,656,196 00Against
Federated Hermes3,632,4300 00For
GEODE CAPITAL MANAGEMENT, LLC3,528,9240 00For
Deep Track Capital, LP2,958,1220 00For
Charles Schwab2,950,8450 00For
FRANKLIN ADVISERS INC2,924,2780 00For
FULLER & THALER ASSET MANAGEMENT, INC.2,419,3780 00For
State Street2,367,8054,215 00For
MUTUAL FUND SERIES TRUST2,341,6500 00For
AllianceBernstein2,206,8510 00For
Goldman Sachs1,889,8280 00For
Columbia Threadneedle1,809,7440 00For
BAILLIE GIFFORD OVERSEAS LTD1,770,7820 00For
Franklin Custodian Funds1,750,0000 00For
LORD, ABBETT & CO. LLC1,746,8910 00For
Capitol Series Trust1,651,8000 00For
BAILLIE GIFFORD & CO LTD1,593,1250 00For
Lord Abbett1,552,7260 00For
John Hancock1,485,0390 00For
WESTFIELD CAPITAL MANAGEMENT CO LP1,325,8740 00For

Showing the 25 largest of 491 asset managers. See all 491 in the interactive database.

2. Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-06-17.

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 73%1 YEAR 24%

The 471 asset managers below cast 100% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 0.6%ABSTAIN: 0.0%ONE YEAR: 72.6%1 YEAR: 24.2%1YR: 2.4%3 YEARS: 0.1%THREE YEARS: 0.1%1-YEAR: 0.0%NOT VOTED: 0.0%1: 0.0%1.0: 0.0%2 YEARS: 0.0%3.0: 0.0%
Largest asset managers voting on “Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named e” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00One Year
T. Rowe Price00 00One Year
Fidelity00 00One Year
BlackRock00 001 Year
Invesco00 00One Year
Capital Group00 001Yr
Federated Hermes00 001 Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Deep Track Capital, LP00 001 Year
Charles Schwab00 001 Year
FRANKLIN ADVISERS INC00 00One Year
FULLER & THALER ASSET MANAGEMENT, INC.00 00One Year
State Street00 00One Year
MUTUAL FUND SERIES TRUST00 00One Year
AllianceBernstein00 00One Year
Goldman Sachs00 00One Year
Columbia Threadneedle00 00One Year
BAILLIE GIFFORD OVERSEAS LTD00 001 Year
Franklin Custodian Funds00 00One Year
LORD, ABBETT & CO. LLC00 00One Year
Capitol Series Trust00 00One Year
BAILLIE GIFFORD & CO LTD00 001 Year
Lord Abbett00 00One Year
John Hancock00 00One Year
WESTFIELD CAPITAL MANAGEMENT CO LP00 00One Year

Showing the 25 largest of 471 asset managers. See all 471 in the interactive database.

3. Election of Class II Directors: Ian Clark

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-17.

Combines 5 wordings of this item as funds reported it.

65% Majority: yes · of votes cast

FOR 65%WITHHELD 35%
FOR: 70,526,891WITHHELD: 37,916,548

Guardant Health, Inc.’s own tally for this item (“Elect Director: Ian Clark”): 70,526,891 for, 37,916,548 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,599,929 outstanding shares: 53.2% for, 29% withheld (82% of the company cast a for/withheld vote).

The 131 asset managers below cast 100% of the shares they voted on this item FOR (48,843,354 for, 0 against).

FOR 77%ABSTAIN 23%
FOR: 48,843,354 (77.0%)ABSTAIN: 14,613,037 (23.0%)NOT VOTED: 152 (0.0%)
Largest asset managers voting on “Election of Class II Directors: Ian Clark” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,124,5700 13,5530For
Fidelity7,481,8530 34,1650For
BlackRock4,372,3970 290,5030For
T. Rowe Price4,136,3330 313,9040For
Capital Group3,309,5970 00For
Invesco3,074,2520 00For
MUTUAL FUND SERIES TRUST2,341,6500 00For
Columbia Threadneedle1,809,7440 00For
Federated Hermes00 1,770,5390Abstain
Franklin Custodian Funds1,750,0000 00For
Capitol Series Trust00 1,651,8000Abstain
Lord Abbett1,552,7260 00For
Charles Schwab1,469,5680 00For
Erste Asset Management GmbH00 815,9170Abstain
Manager Directed Portfolios743,5060 00For
Bridge Builder Trust173,3770 477,6560Abstain
Victory Capital00 564,5400Abstain
Goldman Sachs00 558,7360Abstain
FRANKLIN STRATEGIC SERIES553,2570 00For
American Century00 548,0180Abstain
AllianceBernstein00 517,9220Abstain
ALGER FUNDS00 480,9880Abstain
Jackson National293,5540 172,2820For
ARK ETF Trust446,8820 00For
Equitable192,3090 246,0590Abstain

Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.

4. Election of Class II Directors: Manuel Hidalgo Medina

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-17.

Combines 5 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD 24%
FOR: 81,925,123WITHHELD: 26,518,316

Guardant Health, Inc.’s own tally for this item (“Elect Director: Manuel Hidalgo Medina”): 81,925,123 for, 26,518,316 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,599,929 outstanding shares: 62% for, 20% withheld (82% of the company cast a for/withheld vote).

The 131 asset managers below cast 100% of the shares they voted on this item FOR (52,298,536 for, 0 against).

FOR 82%ABSTAIN 18%
FOR: 52,298,536 (82.4%)ABSTAIN: 11,157,855 (17.6%)NOT VOTED: 152 (0.0%)
Largest asset managers voting on “Election of Class II Directors: Manuel Hidalgo Medina” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,131,6430 6,4800For
Fidelity7,509,4180 6,6000For
BlackRock4,662,9000 00For
T. Rowe Price4,136,3330 313,9040For
Capital Group3,309,5970 00For
Invesco3,074,2520 00For
MUTUAL FUND SERIES TRUST2,341,6500 00For
Columbia Threadneedle1,809,7440 00For
Federated Hermes1,770,5390 00For
Franklin Custodian Funds1,750,0000 00For
Capitol Series Trust00 1,651,8000Abstain
Lord Abbett1,552,7260 00For
Charles Schwab1,469,5680 00For
Erste Asset Management GmbH00 815,9170Abstain
Manager Directed Portfolios743,5060 00For
Bridge Builder Trust325,6350 325,3980For
Victory Capital00 564,5400Abstain
Goldman Sachs7,1950 551,5410Abstain
FRANKLIN STRATEGIC SERIES553,2570 00For
American Century00 548,0180Abstain
AllianceBernstein00 517,9220Abstain
ALGER FUNDS00 480,9880Abstain
Jackson National293,5540 172,2820For
ARK ETF Trust446,8820 00For
Equitable192,3090 246,0590Abstain

Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.

5. Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026.

AUDIT-RELATED

Meeting held 2026-06-17.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 129 asset managers below cast 100% of the shares they voted on this item FOR (62,485,165 for, 0 against).

FOR: 62,485,165 (99.9%)ABSTAIN: 41,734 (0.1%)NOT VOTED: 152 (0.0%)
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered pub” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,138,1220 00For
Fidelity7,516,0180 00For
BlackRock4,662,9000 00For
T. Rowe Price4,450,2370 00For
Capital Group3,309,5970 00For
Invesco3,074,2520 00For
MUTUAL FUND SERIES TRUST2,341,6500 00For
Columbia Threadneedle1,809,7440 00For
Federated Hermes1,770,5390 00For
Franklin Custodian Funds1,750,0000 00For
Capitol Series Trust1,651,8000 00For
Lord Abbett1,552,7260 00For
Charles Schwab1,469,5680 00For
Manager Directed Portfolios743,5060 00For
Bridge Builder Trust651,0330 00For
Victory Capital564,5400 00For
Goldman Sachs558,7360 00For
FRANKLIN STRATEGIC SERIES553,2570 00For
American Century548,0180 00For
AllianceBernstein517,9220 00For
ALGER FUNDS480,9880 00For
Jackson National465,8360 00For
ARK ETF Trust446,8820 00For
Equitable438,3680 00For
Principal392,8150 00For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

6. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-06-17.

100% fund support · no official result

12%1 YEAR 87%

The 10 asset managers below cast 100% of the shares they voted on this item FOR (113,574 for, 0 against).

FOR: 113,574 (11.8%)1 YEAR: 836,939 (86.6%)ONE YEAR: 16,001 (1.7%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH00 001 Year
Brighthouse103,5990 00For
Local Pensions Partnership Investment Ltd00 001 Year
CLEARWATER INVESTMENT TRUST9,9750 00For
Metzler Asset Management GmbH00 00One Year
TD Waterhouse Canada Inc.00 00One Year
GROUPAMA ASSET MANAGMENT00 00One Year
Triasima Portfolio Management inc.00 00One Year
Coyle Financial Counsel LLC00 001 Year
Temasek Holdings (Private) Ltd00 00--

7. Ratify Deloitte & Touche LLP as Auditors

AUDIT-RELATED

Meeting held 2026-06-17.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (929,491 for, 0 against).

FOR: 929,491 (100.0%)
Largest asset managers voting on “Ratify Deloitte & Touche LLP as Auditors” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH815,9170 00For
Brighthouse103,5990 00For
CLEARWATER INVESTMENT TRUST9,9750 00For

8. Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-18 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 91,189,702AGAINST: 7,020,245

Guardant Health, Inc.’s own tally for this item (“Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was approved by the following vote:”): 91,189,702 for, 7,020,245 against, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,599,929 outstanding shares: 69% for, 5% against (74% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (1,552 for, 0 against).

FOR 100%
FOR: 1,552 (100.0%)
Largest asset managers voting on “Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.” at Guardant Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
IMA Advisory Services, Inc.1,4020 00For
Philip James Wealth Mangement, LLC1100 00For
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC400 00For

Largest Guardant Health, Inc. shareholders voting in 2025-2026

Ranked by the number of Guardant Health, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 132,599,929 shares outstanding at the time of that meeting.

Top Guardant Health, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 10.73%
2T. Rowe Price 9.07%
3Fidelity 9.01%
4BlackRock 6.87%
5Invesco 5.30%
6Capital Group 5.02%
7Federated Hermes 2.74%
8GEODE CAPITAL MANAGEMENT, LLC 2.66%
9Deep Track Capital, LP 2.23%
10Charles Schwab 2.23%

Reported Guardant Health, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Guardant Health, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 9.17% 13F
BlackRock 8.71% 13F
T. Rowe Price 5.30% 13F
Invesco 3.73% 13F
Goldman Sachs 3.35% 13F
Two Sigma 3.19% 13F
FMR (Fidelity) 3.10% 13F
Franklin Templeton 2.60% 13F

Percentages above are of 132,599,929 shares outstanding, as reported by Guardant Health, Inc. on its Form 10-Q dated 2026-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Guardant Health, Inc.’s 10-Q dated 2026-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Guardant Health, Inc.'s shareholder meeting held 2026-06-17, in the 2025-2026 proxy season, 495 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,780 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer… — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Guardant Health, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-18.

Guardant Health, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).